H.C. Wainwright raised the firm’s price target on Alnylam to $400 from $395 and keeps a Buy rating on the shares following the Q1 report. The company has shown strong commercial execution on the Amvuttra launch and the highly anticipated HELIOS-B data is on track for late June or early July, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALNY:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue